Semper Paratus Acquisition (LGSTW) Competitors $0.06 -0.01 (-8.69%) As of 06/20/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock LGSTW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, BCTXW, and CELUWShould you be buying Semper Paratus Acquisition stock or one of its competitors? The main competitors of Semper Paratus Acquisition include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), and Celularity (CELUW). These companies are all part of the "pharmaceutical products" industry. Semper Paratus Acquisition vs. Its Competitors 180 Life Sciences 4D pharma Aesther Healthcare Acquisition Ainos Alvotech Atlantic Coastal Acquisition Corp. II Biofrontera biote BriaCell Therapeutics Celularity Semper Paratus Acquisition (NASDAQ:LGSTW) and 180 Life Sciences (NASDAQ:ATNFW) are both financial services companies, but which is the superior stock? We will compare the two businesses based on the strength of their community ranking, valuation, institutional ownership, earnings, media sentiment, risk, profitability, analyst recommendations and dividends. Does the media favor LGSTW or ATNFW? In the previous week, 180 Life Sciences had 1 more articles in the media than Semper Paratus Acquisition. MarketBeat recorded 1 mentions for 180 Life Sciences and 0 mentions for Semper Paratus Acquisition. 180 Life Sciences' average media sentiment score of 0.95 beat Semper Paratus Acquisition's score of 0.00 indicating that 180 Life Sciences is being referred to more favorably in the news media. Company Overall Sentiment Semper Paratus Acquisition Neutral 180 Life Sciences Positive Does the MarketBeat Community favor LGSTW or ATNFW? Semper Paratus Acquisition and 180 Life Sciences both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformSemper Paratus AcquisitionN/AN/A180 Life SciencesN/AN/A Is LGSTW or ATNFW more profitable? Company Net Margins Return on Equity Return on Assets Semper Paratus AcquisitionN/A N/A N/A 180 Life Sciences N/A N/A N/A Which has preferable valuation & earnings, LGSTW or ATNFW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSemper Paratus AcquisitionN/AN/AN/AN/AN/A180 Life SciencesN/AN/AN/AN/AN/A Summary180 Life Sciences beats Semper Paratus Acquisition on 2 of the 2 factors compared between the two stocks. Get Semper Paratus Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for LGSTW and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LGSTW vs. The Competition Export to ExcelMetricSemper Paratus AcquisitionShell Companies IndustryFinancial SectorNASDAQ ExchangeMarket CapN/A$438.87M$6.39B$8.55BDividend YieldN/A5.35%4.13%4.21%P/E RatioN/A0.5913.4219.17Price / SalesN/A452.601,808.31109.12Price / CashN/A196.2049.0155.76Price / BookN/A2.771.395.76Net IncomeN/A-$141.08M$1.25B$248.88M7 Day PerformanceN/A-0.04%0.48%2.13%1 Month PerformanceN/A1.70%2.13%3.78%1 Year PerformanceN/A22.40%15.42%15.59% Semper Paratus Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LGSTWSemper Paratus AcquisitionN/A$0.06-8.7%N/AN/A$0.00N/A0.003ATNFW180 Life SciencesN/A$0.01-2.4%N/A-16.3%$0.00N/A0.007News CoveragePositive NewsGap DownLBPSW4D pharmaN/AN/AN/AN/A$0.00$522K0.00N/AAEHAWAesther Healthcare AcquisitionN/A$0.01+40.8%N/AN/A$0.00N/A0.002Gap UpHigh Trading VolumeAIMDWAinosN/A$0.10-14.0%N/A+139.5%$0.00$106.21K0.0040Positive NewsGap DownALVOWAlvotechN/A$1.87-3.6%N/A-51.0%$0.00$585.60M0.004Positive NewsGap DownACABWAtlantic Coastal Acquisition Corp. IIN/A$0.02+5.2%N/A-68.3%$0.00N/A0.0015Gap UpBFRIWBiofronteraN/A$0.11flatN/A+102.2%$0.00$38.00M0.0070Positive NewsGap DownBTMDWbioteN/A$0.03flatN/A-95.9%$0.00$199.38M0.00N/ABCTXWBriaCell TherapeuticsN/A$0.08+0.7%N/A-79.8%$0.00N/A0.008News CoverageShort Interest ↑Gap DownCELUWCelularityN/A$0.05flatN/A+175.2%$0.00$54.22M0.00220 Related Companies and Tools Related Companies 180 Life Sciences Alternatives 4D pharma Alternatives Aesther Healthcare Acquisition Alternatives Ainos Alternatives Alvotech Alternatives Atlantic Coastal Acquisition Corp. II Alternatives Biofrontera Alternatives biote Alternatives BriaCell Therapeutics Alternatives Celularity Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LGSTW) was last updated on 6/22/2025 by MarketBeat.com Staff From Our Partners[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredThe Biggest Story of My Decade-Long Career in Silicon ValleySteve Jobs' Lost 'Product' Could Save Tesla On July 21st, a revolutionary announcement could transform Tesl...InvestorPlace | Sponsored379 passengers walked away from thisElon Musk just wrote a $51 million check to back this material’s next phase… Because it’s not just saving l...True Market Insiders | SponsoredA grave, grave error.It seems like the world is on fire. Trump’s tariffs are crippling economies worldwide. Canada’s been cri...Porter & Company | SponsoredMost Bitcoin holders have no idea this existsHere’s what 99% of Bitcoin holders don’t know: There’s a way to amplify your Bitcoin gains without buying m...Brownstone Research | SponsoredBanks aren’t ready for this altcoin—are you?The Secret Crypto That Billionaires Are Hoarding When these hit, the current price will look like pocket ch...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Semper Paratus Acquisition Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Semper Paratus Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy LGSTW Stock Free LGSTW Stock Alerts